EP0466820B1 - Gegenstände zur behandlung von periodontitis und knochendefekten - Google Patents

Gegenstände zur behandlung von periodontitis und knochendefekten Download PDF

Info

Publication number
EP0466820B1
EP0466820B1 EP90906608A EP90906608A EP0466820B1 EP 0466820 B1 EP0466820 B1 EP 0466820B1 EP 90906608 A EP90906608 A EP 90906608A EP 90906608 A EP90906608 A EP 90906608A EP 0466820 B1 EP0466820 B1 EP 0466820B1
Authority
EP
European Patent Office
Prior art keywords
article
connective tissue
bone
tissue
defect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP90906608A
Other languages
English (en)
French (fr)
Other versions
EP0466820A1 (de
Inventor
Todd V. Scantlebury
Jeanne B. Ambruster
Suzanne Motsinger
Daniel F. Davidson
William Ross Hardwick
Stephen E. Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WL Gore and Associates Inc
Original Assignee
WL Gore and Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/333,289 external-priority patent/US5032445A/en
Application filed by WL Gore and Associates Inc filed Critical WL Gore and Associates Inc
Publication of EP0466820A1 publication Critical patent/EP0466820A1/de
Application granted granted Critical
Publication of EP0466820B1 publication Critical patent/EP0466820B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0003Not used, see subgroups
    • A61C8/0004Consolidating natural teeth
    • A61C8/0006Periodontal tissue or bone regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0012Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2846Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2835Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/23Sheet including cover or casing
    • Y10T428/239Complete cover or casing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24058Structurally defined web or sheet [e.g., overall dimension, etc.] including grain, strips, or filamentary elements in respective layers or components in angular relation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24058Structurally defined web or sheet [e.g., overall dimension, etc.] including grain, strips, or filamentary elements in respective layers or components in angular relation
    • Y10T428/24124Fibers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24479Structurally defined web or sheet [e.g., overall dimension, etc.] including variation in thickness
    • Y10T428/24496Foamed or cellular component
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24777Edge feature
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24942Structurally defined web or sheet [e.g., overall dimension, etc.] including components having same physical characteristic in differing degree
    • Y10T428/2495Thickness [relative or absolute]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/249921Web or sheet containing structurally defined element or component
    • Y10T428/249953Composite having voids in a component [e.g., porous, cellular, etc.]
    • Y10T428/249987With nonvoid component of specified composition
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/28Web or sheet containing structurally defined element or component and having an adhesive outermost layer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/3154Of fluorinated addition polymer from unsaturated monomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/3154Of fluorinated addition polymer from unsaturated monomers
    • Y10T428/31544Addition polymer is perhalogenated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31551Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31652Of asbestos
    • Y10T428/31663As siloxane, silicone or silane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31786Of polyester [e.g., alkyd, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31855Of addition polymer from unsaturated monomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31855Of addition polymer from unsaturated monomers
    • Y10T428/31935Ester, halide or nitrile of addition polymer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31855Of addition polymer from unsaturated monomers
    • Y10T428/31938Polymer of monoethylenically unsaturated hydrocarbon

Definitions

  • the present invention provides articles for treatment of bony defects. Although examples described herein relate to bone defects in the mouth, similar treatment is applicable throughout the human body.
  • a bony defect is any unnatural or irregular anatomy of the bone structure, particularly where bone is missing from the natural anatomy. Bone defects are commonly found in the oral cavity including the jaw bone, and are often the result of traumatic injury to the teeth and bone, disease affecting pulp canals of the teeth, periodontal disease, tooth root fractures, tumors, cancer, or congenital defects.
  • the natural grafting materials include iliac, rib, or oral bone harvested from the patient who will receive the graft (i.e. autogenous), cortical or cancellous bone harvested from an individual different from the patent (i.e., allogenous), or cortical or cancellous bone harvested from a different mammalian species (i.e. xenogenour).
  • Synthetic materials include particles or blocks of either solid or porous hydroxylapatite, particles or blocks of synthetic polymers such as poly (methylmethacrylate) or processed collagenous material usually obtained from a bovine source.
  • bone cells and fibrous connective tissue cells compete to fill the void space within the graft material or to replace the graft material as it resorbs.
  • fibrous connective tissue can grow and form faster than bone tissue, the above-mentioned graft materials may attach or be partly ingrown with bone; however, the majority of healing is accomplished by ingrowth of soft connective tissue.
  • the particles tend to migrate over time through the soft tissue beyond the margins of the bone defect thereby reducing or minimizing therapeutic results.
  • the second major problem is that all of the above-mentioned materials are prone to either dehiscence of the suture line due to stretching the gingival tissue over them during closure of the surgical site or perforation of the graft material through the gingival tissue at some point after initial healing has occurred. In either case, exposure of the graft material occurs with subsequent infection and loss of graft material.
  • WO-A-86-00517 describes an article for use in prosthetic implants and capable of supporting preferential connective tissue growth and/or attachment for treating bone defects.
  • the article comprises a flexible, flattened member, respective portions defining first and second juxtaposed surfaces.
  • the second surface which is impermeable, surrounds the first surface which is porous and capable of supporting connective tissue ingrowth and/or attachment.
  • the permeable first surface surrounds the second surface which is impermeable to connective tissue ingrowth and/or attachment and to bacteria.
  • the invention provides a biocompatible porous article for successful treatment of bony defects particularly in the jaw bone of the mouth. Treatment involves placement of the article over the bony defect thus creating a space between the article and the bone in the region of the defect into which bone cells proliferate.
  • the article itself protects the defect space thus created from epithelium, fibrous connective tissue, and bacteria all of which would normally be detrimental to bone tissue healing within the defect region.
  • the article thus allows predictable resolution of bony defects even in the event of exposure of the article to the oral or outside environment through dehiscence of the suture line, perforation of the overlying soft tissue or inability to obtain primary or complete closure of the soft tissue.
  • Figure 1 is a three-dimensional view of uniaxially expanded polytetrafluoroethylene.
  • Figure 2 is a three-dimensional view of an embodiment of a prior art article described in Examples 1 and 2 wherein a first portion of the article is porous and a second portion of the article is substantially impermeable to oral tissues.
  • Figure 2A is a cross-sectional view of the embodiment of Figure 2 taken along line A-B.
  • Figure 3 is a three-dimensional view of a bony defect in the alveolar ridge wherein the mucoperiosteal flaps have been elevated thereby leaving the alveolar bone ridge exposed.
  • Figure 4 is a three-dimensional view of a bony defect in the alveolar ridge similar to that of Figure 3 repaired with an embodiment of the invention.
  • Figure 5 is a bucco-lingual cross-sectional view of the inventive embodiment placed over the alveolar ridge bony defect and mucoperiosteal flap resutured over the article.
  • Figure 5A is a view similar to that in Figure 5 but showing the addition of bone filler material to the defect.
  • Figure 5B is a view similar to that in Figure 5 but showing dehiscence at the juncture of the mucoperiosteal flaps.
  • Figure 6 is a surface view of the inventive embodiment and configured for treatment of bony defects wherein a first peripheral surface of the article is capable of supporting tissue ingrowth and a second central surface of the article is impermeable to tissue ingrowth.
  • Figure 6A is a cross-sectional view of Figure 6 taken along line E-F.
  • Figure 6B shows an alternative construction similar to that in Figure 6 but having wire reinforcements.
  • Figure 6C is a cross-sectional view of the construction shown in Figure 6B taken along line C-C.
  • Figure 7 is a bucco-lingual cross-sectional view of the inventive embodiment wherein a dental implant is placed within the alveolar ridge defect underlying the article.
  • the present invention provides articles for the treatment of defects in bones, particularly in the jaw bone of the mouth.
  • the mucoperiosteal flaps 101 including the gingival epithelium 103 and gingival connection tissue 105 are separated from the alveolar ridge of the jaw bone 107 leaving exposed the bony defect 109.
  • one embodiment of the article 120 comprising a flexible, flattened member having first and second juxtaposed surfaces meeting at a boundary is positioned over the affected region of the bone and is fixed in a laminar relationship to a portion of the alveolar ridge.
  • the first surface 121 is formed of a porous, biocompatible material capable of supporting the ingrowth of connective tissue and thus preventing or retarding the migration of gingival epithelium into the defect region.
  • This first surface is configured to be peripheral to a second surface and sized and configured so as to surround the perimeter of the defect area, and adapt closely to the contours of the bone adjacent to the defect area when the article is in place.
  • the second surface 123 is preferably configured so that it is surrounded by the first surface.
  • the second surface is formed of a material substantially impermeable to oral tissues and bacteria and configured to fully cover the bony defect.
  • the second surface also creates a space (e.g.
  • Figure 5 space 131) between the surface and bone defect to allow bone cells to proliferate within the space without competition from cells originating from the fibrous connective tissue and epithelium. This results in filling of the defect space by viable bone tissue. Because the article will protect the defect space from epithelium, gingival connective tissue, and bacteria, bone tissue will fill the space even in the event that the article is exposed to the outside environment due to suture line dehiscence, perforation, or inability to obtain primary or complete closure of the overlying tissue. In some situations, complete closure of the tissue may not be possible (e.g., sites where a tooth is extracted leaving a gap in the soft tissue). In these cases the tissue should be closed as much as possible and stabilized with sutures. Also, allogenous, autogenous, or alloplastic materials 134 ( Figure 5A) can optionally be used to help fill the bony defect by providing a matrix for bone cell growth and/or to prevent collapse of the article into the defect space.
  • the mucoperiosteal flaps are repositioned so that soft tissue completely covers the implanted material 121 and 123, and the flaps are sutured closed 133.
  • the article may be further secured in the area of the defect with various biocompatible glues, sutures, filaments and the like.
  • the present invention is intended to function satisfactorily even in the event of dehiscence of the flaps at their juncture, as is depicted at 137 in Figure 5B.
  • the materials comprising either of the articles for treatment of bony defects be similar to those described in WO-A-86/00517 and be made from biocompatible materials.
  • the porous material must also allow for the rapid ingrowth of gingival connective tissue to inhibit the apical migration of gingival epithelium along the surface of the material.
  • the porous material is soft and flexible so that it will conform to the curvature of the tooth and surrounding bone and not cause tissue necrosis in the tissues against which it is placed.
  • Suitable biocompatible materials which can be made porous include, but are not limited to, silicones, polyurethanes, polyethylenes, polysulfones, polyacrylics, polycarboxylates, polyesters, polypropylenes, poly(hydroxyethylmethacrylates), and perfluorinated polymers, such as fluorinated ethylene propylene, and polytetrafluoroethylene.
  • the above-mentioned may be made porous by any techniques known to those of ordinary skill in the art which will render the materials capable of supporting gingival connective tissue ingrowth while preventing apical migration of gingival epithelium.
  • Such techniques include, but are not limited to, sintering carefully controlled sizes of beads; combining the materials with a partially resorbable implant that would resorb or could be resorbed, in vivo or in vitro, to leave a porous surface; weaving or knitting fibers together to form a fabric-like material; or using a foaming agent during processing to cause bubbles to form and leave pores as the material hardens.
  • the porous material may be treated or filled with biologically active substances such as antibiotics, fibrin, thrombin, and collagen. These substances may enhance connective tissue formation within the porous material and inhibit infection during healing.
  • Each of the articles may be comprised of a suitable bioresorbable, biodegradable, or hydrolyzable material so that the article dissolves over a period of time. It is most preferred, however, that the porous material be expanded polytetrafluoroethylene (PTFE) which is subsequently processed to a desired microstructure such as by application of heat and pressure. Expanded PTFE is an extremely inert and biocompatible material with a history of medical implant use. U.S. Patent Numbers 3,953,566 and 4,187,390, the disclosures of which are incorporated herein by reference, teach methods for producing expanded PTFE and characterize its porous structure. The porous structure of expanded PTFE is further illustrated in Figure 1. The microstructure of expanded PTFE is a three-dimensional matrix of nodes 9, connected by fibrils 10.
  • the pore size of expanded PTFE can be characterized by determining the bubble point and the mean flow pressure of the material. Bubble point and mean flow pressure are measured according to the American Society for Testing and Materials Standard F316-80 using ethanol.
  • the density of expanded PTFE determines the amount of void space in the material which may become ingrown with connective tissue.
  • the density of expanded PTFE is the ratio of the mass of a given sample of expanded PTFE to its volume.
  • the fibril length of expanded PTFE is defined herein as the average of ten measurements between nodes connected by fibrils in the direction of expansion.
  • Figure 1 illustrates material expanded in one direction only, PTFE expanded in more than one direction is thought to be equally applicable to the invention.
  • two parallel lines are drawn across a photomicrograph of about 40 to 50 times magnification of the surface of the material so as to divide the photograph into three equal areas. If the material has been uniaxially expanded, these lines are drawn in the direction of expansion (i.e., direction of orientation of fibrils).
  • a preferred parameter used to characterize the microstructure is the internodal distance of expanded PTFE rather than fibril length. Internodal distance is defined herein as the average distance between edges of nodes in the direction of expansion based on at least 20 random measurements of internodal distance from three fields of view at 200X. Measurements were made on a Nikon medical research microscope.
  • the articles of the invention include one embodiment, which comprises a layered structure wherein a first layer having a porous surface capable of supporting ingrowth or attachment of connective tissue is arranged in laminar relationship with a second support layer which is substantially impermeable and incapable of penetration by tissues or bacteria.
  • the first porous layer allows fibrous connective tissue ingrowth into the porous material or attachment along the outer surface of the porous material to inhibit or retard epithelial migration.
  • the backing layer substantially prevents undesirable tissue and bacteria from entering the space of the bony defect and allows desirable bone cells to proliferate in the space created by the layered article.
  • the second embodiment, and the most preferred article, for treatment of bony defects is shown in Figures 6, 6A, 6B and 6C and comprises an integral member having a portion with a first porous compressed surface 121 with an average internodal distance greater than 8 microns and preferably in the range of 15-20 microns, a wall thickness of about 0.20mm (0.008 inches) and a density of about 1.0 g/cc.
  • the member also has a second surface 123 positioned to be central to and surrounded by the first surface which is juxtaposed in planar relationship thus forming a boundary encircling the second surface.
  • the portion of the member forming the second surface is more greatly compressed so that it is substantially impermeable to oral tissues and bacteria; however there may be some tissue attachment topically along the second surface.
  • the portion of the member forming the second surface preferably has an average internodal distance of less than 5 microns, a density of about 1.5 g/cc and a wall thickness of about 0.13mm (0.005 inches). These articles may be of laminar or integral construction.
  • Figure 6 shows the preferred shape for the article for treating a bone defect wherein the article has a rectangular shape, the center of which has a further compressed oval shaped region.
  • Figure 6A shows the member in cross-section with the more compressed region in the center.
  • Alternative shapes, sizes and configurations are intended to be within the scope of the articles of this invention for treatment of bony defects.
  • the article used in the treatment of bony defects may be used in conjunction with bone filler materials including but not limited to autogenous, allogenous, or xenogenous bone; synthetic bone materials such as hydroxylapatite, tricalcium phosphates or polymeric materials including bioresorbable, biodegradable, or hydrolyzable sponges, particles, gels or blocks of material.
  • bone filler materials including but not limited to autogenous, allogenous, or xenogenous bone; synthetic bone materials such as hydroxylapatite, tricalcium phosphates or polymeric materials including bioresorbable, biodegradable, or hydrolyzable sponges, particles, gels or blocks of material.
  • the articles for treatment of bony defects may be used in conjunction with biologically active materials or molecules including but not limited to cell activators, antibiotics, or materials which serve as a structural framework for cellular migration such as collagen, fibronectin, or fibrin.
  • biologically active materials may be bound to the surface of the article, incorporated into it so that they may be released in a controlled fashion over a period of time, or placed within the bony defect space protected by the article.
  • the articles for the treatment of bony defects may also incorporate biocompatible reinforcement components such as metallic (e.g., titanium) or polymeric wires, struts, or meshes to allow molding or shaping of the article to specific configurations or to support the article and prevent its collapse into the defect space.
  • biocompatible reinforcement components such as metallic (e.g., titanium) or polymeric wires, struts, or meshes to allow molding or shaping of the article to specific configurations or to support the article and prevent its collapse into the defect space.
  • Such reinforcement means can, for example, comprise optional wire supports 135 at least partially attached to article 120, as shown in Figures 6B and 6C.
  • the article may be used in conjunction with a dental implant as shown In Figure 7 and described in Example 3 wherein the implant 150 is placed in the defect region and the article 120 of the invention is placed over it and extends over the bone ridge.
  • All articles of the present invention are preferably sterilized prior to insertion into a periodontal pocket or covering a bone defect.
  • the articles are sterilized and are contained in a package, the interior environment of which is sterile.
  • Ponchos similar to that shown in Figure 9 of WO-A-86/00517 illustrated in Figure 2 were made with a starting material of expanded PTFE made in accordance with the description in Patent Nos. 4,187,390 and 3,953,566.
  • the poncho had a center 18 which forms a first porous surface and an outer circumference 20 which forms a second impermeable surface.
  • the starting material had an ethanol bubble point of below about 5.17 x 104 dyne/cm2 (0.75 psi), an ethanol mean flow pressure below about 2.07 x 105 dyne/cm2 (3 psi), an average fibril length greater than 100 microns, a density of about 0.3 to 0.1 g/cc, and a wall thickness of about 1mm.
  • a sheet of the starting material was clamped into a metal frame to hold the material in place.
  • the frame was positioned between two plates that had been fixed on a pneumatic press. Each plate was machined so that a rectangular central portion having dimensions of 4mm x 12mm was relieved such that compression of the expanded PTFE would take place peripheral to the central relieved area but not within the central relieved area.
  • the central relieved area remained porous with an open structure. Shims were used in the press as stops to control the degree of compression. The shims were arranged to prevent the plates from contacting each other by about 0.007 inches.
  • the plates were heated to between 300°F and 400°F and the expanded PTFE was compressed between the heated plates for about thirty seconds.
  • the resulting compressed region of expanded PTFE had a density of about 1.0 g/cc and a wall thickness of about 0.18mm (0.007 inches).
  • the compressed region also had internodal distances ranging from about 5 microns to 50 microns with an estimated mean internodal distance of about 15 to 20 microns.
  • the resulting membrane was thus similar in shape to the poncho illustrated in Figure 2 with a central surface of open-structured porous PTFE and a peripheral surface of compressed expanded PTFE.
  • ponches Six of these ponches were implanted into five dogs.
  • Buccal and lingual full-thickness mucoperiosteal flaps were elevated and buccal or circumferential periodontal defects were surgically created on mandibular pre-molar teeth.
  • Each poncho was placed over the teeth with the open-structure porous region adapted closely to the tooth surface at or just apical to the cementoenamel junction. The compressed, less porous, peripheral portion of each poncho was carefully trimmed so that the defined surface completely covered the bony margins of the defect.
  • the mucoperiosteal flaps were repositioned so that the soft tissue completely covered the implanted material and the flaps were sutured closed.
  • the dogs were sacrificed at various time intervals between one and three months post-operatively and the experimental teeth were removed en bloc for histological processing and evaluation.
  • histologically it was found that the epithelium had not migrated past the porous central region of the ponchos and that the porous central regions were extensively ingrown with connective tissue and mononuclear cells. It was found also that some connective tissue had grown within the compressed peripheral region where the internodal distances were greater than 8-10 microns with more tissue ingrown where the internodal distances were greater than 15 microns. In many instances, the connective tissue penetrated the full wall thickness of this peripheral region. However, because of the ingrowth of connective tissue in this compressed peripheral region, epithelium could not migrate along the compressed region in the event that the open-structured porous region became exposed to the oral environment.
  • New cementum with collagen fibers was present on the previously denuded root surface and varying amounts of new bone tissue had healed into the defect space between the patch and the tooth root.
  • Expanded PTFE ponchos with integral two-part constructions were made similar to that described In Example 1.
  • compression of the compressed peripheral region was increased by reducing the shim stop thickness to 0.005 inches.
  • Ponchos of this type were implanted into surgically created periodontal defects on dog premolars similar to that described in Example 1. The dogs were sacrificed at various time intervals between one and three months post-operatively and the experimental teeth removed en bloc and processed for histological evaluation.
  • the coronal margin of the flap was located apical to the porous region of the poncho thereby exposing this region and a portion of the compressed region to the oral environment.
  • the epithelium was located about 1.5 to 2 mm apical to the junction between the porous region and the compressed region of the ponchos.
  • a Brown-Brenn bacteria stain showed the presence of gram positive bacteria throughout the interstices of the open-structured porous regions and on the surface of the compressed portion of the ponchos which was exposed to the oral environment.
  • the tube was restrained longitudinally and heat trated about 375°C for about 75 seconds.
  • the expanded PTFE tube was then slit longitudinally through its walls and laid flat.
  • the wall was about 1mm thick and had nodes passing through its wall thickness.
  • the ethanol bubble point of the material was about 3.45 x 104 dyne/cm2 (0.5 psi) and the ethanol mean flow pressure was about 6.89 x 104 dyne/cm2 (1.0 psi).
  • the average fibril length was about 200 microns and the density was approximately 0.2 g/cc.
  • the patch did not have two juxtaposed surfaces formed by materials of different relative porosity but the entire patch was compressed so that the article implanted in each subject consisted of compressed expanded PTFE with a density of about 1.5 g/cc and a wall thickness of about 0.13mm (0.005 inches).
  • the internodal distance was about 5 to 10 microns.
  • the dimensions of each article were about 30mm x 40mm.
  • the articles were implanted into six sites in humans where bony alveolar ridge defects were present and prevented or compromised placement of dental implants.
  • Vertical incisions were made across the alveolar ridge crest mesial to the bony ridge defect and distal to sites proposed for dental implant placement. These incisions were connected on the labial side of the ridge by a horizontal incision placed apical to the mucogingival junction.
  • Full thickness mucoperiosteal pedicle flaps were elevated and receptor holes drilled in the bone to accept dental implants.
  • the dental implants were then placed into the prepared receptor sites. In each case a portion of the implant was not surrounded by bone because of the bony defect.
  • a particulate hydroxyapatite material was used as a filler in the defect to prevent the article from collapsing into the defect and space below. In the other three cases, no filler or support was provided.
  • the sterile patches were trimmed to the appropriate size and were draped over the bony defect and surrounding area and the dental implant.
  • the flaps were replaced and sutured to enclose the patches.
  • Post-operative healing events were uneventful in 4 of the 6 sites. At one month post-operative, two of the sites showed perforation of the gingival tissue by the patches. Each article was removed by elevating the gingival tissue and peeling the patch off of the bony surface. Upon removal of each patch, it was observed that the defect space had filled with a hard, apparently calcified, bone-like tissue. The gingival tissue flaps were replaced and sutured and the sites were allowed to heal for an additional two to five months prior to placement of abutment posts and bridgework.
  • the patches were used to create and protect a bony defect space into which viable bone tissue could grow.
  • the defect space would have filled with fibrous connective or scar tissue, thus compromising the function of the dental implant.
  • These cases were ideal because enough space existed mesial and distal to the defect sites to prepare the pedicle flaps. This prevented any suture lines from being located directly over the articles.
  • patches having regions of compressed expanded PTFE with internodal distances greater than or equal to 8 microns showed predictable connective tissue ingrowth with greater permeation as the internodal distances increased (i.e., leaving the membrane more porous) and corresponding increased potential for permeation of bacteria.
  • the preferred article for treating bony defects is comprised of an integral flexible flattened patch or member, preferably of expanded PTFE having two juxtaposed surfaces exhibiting differing average internodal spacings.
  • a central region 123 of the member was compressed to a sufficient degree, such that it was made substantially impermeable to oral tissues and bacteria.
  • the second region less compressed and thus more porous is peripheral to the central, highly compressed region.
  • This peripheral region would be capable of preferential connective tissue ingrowth for inhibition of epithelial migration and should extend beyond the margins of the bony alveolar ridge defect. It has been found that compressed expanded PTFE with an internodal distance greater than about 8 microns and density of about 1.0 g/cc is preferred for the peripheral region.
  • a defect space can be created and protected from invasion by gingival connective and epithelial tissues and bacteria. This protected space thus creates an opportunity for bone cells to proliferate and fill the defect with viable bone tissue.
  • the two-part member is designed to be removed after adequate healing has occurred, generally after 1 month; however, in applications where exposure of the article is unlikely the two-part member may remain in place for the life of the patient.

Claims (12)

  1. Ein Erzeugnis (120) zur Verwendung in prothetischen Implantaten und mit der Fähigkeit zum Unterstützen eines bevorzugten Bindegewebs-Hineinwachstums und/oder einer bevorzugten Bindegewebs-Anheftung zur Behandlung von Knochendefekten, wobei das Erzeugnis ein biegsames, abgeflachtes Element aufweist, das jeweilige Abschnitte besitzt, die erste (121) und zweite (123) nebeneinander angeordnete Oberflächen definieren, wobei die genannte erste Oberfläche (121) vollständig die genannte Zweite Oberfläche umgibt,
    dadurch gekennzeichnet,
    daß die genannte erste Oberfläche dazu befähigt ist, das Bindegewebs-Hineinwachstum und/oder die Bindegewebs-Anheftung zu unterstützen, und die erste Oberfläche eine Permeabilität für das Bindegewebs-Hineinwachstum aufweist, welche größer als diejenige der zweiten Oberfläche ist, und daß die genannte zweite Oberfläche eine Bakterienpermeabilität aufweist, die gegenüber derjenigen der ersten Oberfläche unterschiedlich ist, und für Bakterien und für Bindegewebs-Hineinwachstum im wesentlichen undurchlässig ist.
  2. Das Erzeugnis gemäß Anspruch 1, bei welchem das genannte Element (120) ein einstückiges Element ist.
  3. Das Erzeugnis gemäß Anspruch 1, weiterhin umfassend Mittel (135) zum Tragen des genannten Elementes in einer sich anpassenden Beziehung zu dem Knochen in der Umgebung des Defektes.
  4. Das Erzeugnis gemäß Anspruch 3, bei welchem die genannten Träger-Mittel (135) Draht-Mittel aufweisen, welche in dem genannten Element eingebettet sind.
  5. Das Erzeugnis gemäß Anspruch 4, bei welchem die genannten Draht-Mittel (135) Titandraht umfassen.
  6. Das Erzeugnis gemäß Anspruch 1, bei welchem die genannte erste Oberfläche durch ein Material aus expandiertem Polytetrafluorethylen gebildet ist, das einen Zwischenknoten-Abstand von größer als oder gleich zu 8 Mikron und eine Dichte von ungefähr 1,0 g/cm³ aufweist.
  7. Das Erzeugnis gemäß Anspruch 6, bei welchem das genannte Element einstückig ausgeformt ist, und bei welchem die Stärke der genannten Abschnitte der Elemente, welche die erste Oberfläche (121) und die zweite Oberfläche (123) bilden, jeweils ungefähr 0,20 mm (0,008 inches) und ungefähr 0,13 mm (0,005 inches) beträgt.
  8. Das Erzeugnis gemäß Anspruch 1, bei welchem eine biologisch wirksame Substanz in freisetzbarer Weise in dem genannten Element vorhanden ist.
  9. Das Erzeugnis gemäß Anspruch 1, bei welchem zumindest die Elementen-Abschnitte (121) mit der größeren Permeabilität aus einem oder mehreren bioverträglichen Materialien hergestellt sind, die ausgewählt sind aus der Gruppe bestehend aus Silikonen, Polyurethanen, Polyethylenen, Polysulfonen, Polyacryl-Werkstoffen, Polycarboxylaten, Polyestern, Polypropylenen, Poly(Hydroxyethyl)-Methacrylaten, und perfluorierten Polymeren.
  10. Das Erzeugnis gemäß Anspruch 5, bei welchem die genannten Träger-Mittel (135) ein polymeres Netz umfassen.
  11. Das Erzeugnis gemäß Anspruch 1, bei welchem der genannte, die genannte zweite Oberfläche (123) definierende Abschnitt des Elementes aus einem oder mehreren bioverträglichen Materialien hergestellt ist, die aus der Gruppe ausgewählt sind, bestehend aus Silikonen, Polyurethanen, Polyethylenen, Polysulfonen, Polyacryl-Werkstoffen, Polycarboxylaten, Polyestern, Polypropylenen, Poly(Hydroxyethyl)-Methacrylaten und polyfluorierten Polymeren.
  12. Das Erzeugnis gemäß Anspruch 1, bei welchem die genannte zweite Oberfläche in Bezug auf die genannte erste Oberfläche mittig angeordnet ist.
EP90906608A 1989-04-05 1990-04-04 Gegenstände zur behandlung von periodontitis und knochendefekten Expired - Lifetime EP0466820B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/333,289 US5032445A (en) 1984-07-06 1989-04-05 Methods and articles for treating periodontal disease and bone defects
PCT/US1990/001824 WO1990011730A1 (en) 1989-04-05 1990-04-04 Methods and articles for treating periodontal disease and bone defects
US333289 1994-11-02

Publications (2)

Publication Number Publication Date
EP0466820A1 EP0466820A1 (de) 1992-01-22
EP0466820B1 true EP0466820B1 (de) 1995-04-05

Family

ID=23302161

Family Applications (1)

Application Number Title Priority Date Filing Date
EP90906608A Expired - Lifetime EP0466820B1 (de) 1989-04-05 1990-04-04 Gegenstände zur behandlung von periodontitis und knochendefekten

Country Status (6)

Country Link
US (1) US5093179A (de)
EP (1) EP0466820B1 (de)
JP (1) JP2905592B2 (de)
DE (1) DE69018457T2 (de)
HK (1) HK165695A (de)
WO (1) WO1990011730A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700479A (en) * 1988-12-23 1997-12-23 Guidor Ab Surgical element and method for selective tissue regeneration
DE69121587T3 (de) * 1990-12-06 2000-05-31 Gore & Ass Implantierbare bioresorbierbare artikel
US5378152A (en) * 1992-05-01 1995-01-03 Dental Marketing Specialists, Inc. Method and apparatus for installation of dental implant
US5397235A (en) * 1993-07-02 1995-03-14 Dental Marketing Specialists, Inc. Method for installation of dental implant
JPH08502665A (ja) * 1992-08-05 1996-03-26 グイドール アクティエボラーグ 選択的組織再生のための外科用要素及び方法
US6019764A (en) * 1993-08-02 2000-02-01 Bartee; Barry K. Method of treating alveolar bone defects
US5455041A (en) * 1993-09-13 1995-10-03 Research Foundation Of State University Of New York At Buffalo Method for inducing periodontal tissue regeneration
US5792508A (en) * 1993-09-16 1998-08-11 Kanebo Ltd. Materials for treatment of periodontal disease
JPH09509081A (ja) * 1994-02-17 1997-09-16 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド 切削可能なptfe移植材料
DE19520866C2 (de) * 1995-06-08 1998-04-16 Kirsch Axel Vorrichtung zum Behandeln einer Knochenausnehmung
US5769637A (en) * 1996-05-22 1998-06-23 Sofamor Danek Properties, Inc. Dental implant and alveolar process augmentation structures and method of installation
US5674074A (en) * 1996-06-13 1997-10-07 Angelo, Jr.; Patrick J. Periodontal procedure
US5727945A (en) * 1996-08-26 1998-03-17 Dannenbaum; Richard M. Impregnated barrier and method of assisting bone or tissue regeneration
US6251419B1 (en) 1997-04-22 2001-06-26 Hans Georg Graber Membrane system for controlled tissue regeneration in cases of diseases of the periodontium
US5957690A (en) * 1997-11-17 1999-09-28 Bartee; Barry K. Textured high density PTFE medical barrier
US6110484A (en) * 1998-11-24 2000-08-29 Cohesion Technologies, Inc. Collagen-polymer matrices with differential biodegradability
US6155831A (en) * 1999-03-03 2000-12-05 Mcguire; Michael K. Non-surgically retrievable guided tissue regeneration membrane
US6402518B1 (en) * 1999-11-30 2002-06-11 Arthur Ashman Method and apparatus for performing ridge augmentation
US20060094112A1 (en) * 2001-03-07 2006-05-04 Omotunde Babalola Biological scaffold
US20030105530A1 (en) * 2001-12-04 2003-06-05 Inion Ltd. Biodegradable implant and method for manufacturing one
US20030171451A1 (en) * 2002-03-11 2003-09-11 White Daniel A. Bony tissue fillers and restoratives containing biocompatible particle
US7296998B2 (en) * 2003-09-22 2007-11-20 Bartee Chaddick M Hydrophilic high density PTFE medical barrier
DE102004035090A1 (de) * 2004-07-20 2006-02-16 Sirona Dental Systems Gmbh Ausgleichsteil und Verfahren für die Vermessung von Zahnrestaurationen
US7789888B2 (en) * 2005-02-14 2010-09-07 Bartee Chad M PTFE composite multi-layer material
US20080206709A1 (en) * 2007-02-27 2008-08-28 Lannan William G Gingival support sleeve
WO2010096824A1 (en) * 2009-02-23 2010-08-26 Bartee Barry K Reinforced ptfe medical barrier
US9012530B2 (en) * 2010-07-30 2015-04-21 Warsaw Orthopedic, Inc. Bioadhesive for periodontal gingival and/or bone tissues
US8857442B1 (en) 2012-03-05 2014-10-14 Gloria A. Ospina High lip-line smile corrective surgical method
GB2529488B (en) 2014-09-30 2016-09-28 Neoss Ltd Reinforced membrane
WO2017010811A1 (ko) * 2015-07-13 2017-01-19 한양대학교 산학협력단 맞춤형 치조골 조직 및 그 제조 방법
EP3231391B1 (de) 2016-04-14 2018-12-26 Neoss Limited Schraubendreher und schraube für medizinische anwendungen, insbesondere für zahnärztliche anwendungen
US20220313872A1 (en) * 2019-08-12 2022-10-06 Corneat Vision Ltd Gingival graft

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748781A (en) * 1953-08-24 1956-06-05 Collat Edgar Means for dental hygiene
US2991224A (en) * 1958-08-18 1961-07-04 Dale V Bell Gingival pack
US3386440A (en) * 1965-10-19 1968-06-04 Milton J. Cohen Dental pad
FR1499912A (fr) * 1966-03-10 1967-11-03 Plateau de protection radiculaire
US3589011A (en) * 1969-07-10 1971-06-29 Meer Sneer Endosseous pin dental implant method and dental devices used therein
CA962021A (en) * 1970-05-21 1975-02-04 Robert W. Gore Porous products and process therefor
CA962806A (en) * 1970-06-04 1975-02-18 Ontario Research Foundation Surgical prosthetic device
US3754332A (en) * 1970-09-09 1973-08-28 L Warren Treatment member
SE393290B (sv) * 1971-05-20 1977-05-09 Vitek Inc Materialkomposition till anvendning for implantation in vivo, vilken komposition innehaller en fibros, poros struktur samt forfarande for framstellning av en sadan komposition
FR2155073A5 (de) * 1971-10-06 1973-05-18 Rhone Poulenc Sa
US3879767A (en) * 1972-01-26 1975-04-29 Cutter Lab Prosthesis for articulating body structures
US3909852A (en) * 1973-12-17 1975-10-07 Charles A Homsy Implantable substitute structure for at least part of the middle ear bony chain
US4039653A (en) * 1974-01-23 1977-08-02 Defoney, Brenman, Mayes & Baron Long-acting articles for oral delivery and process
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
FR2278317A1 (fr) * 1974-07-19 1976-02-13 Commissariat Energie Atomique Implant buccal pour administrer des produits solubilisables
US3971134A (en) * 1975-01-31 1976-07-27 General Atomic Company Carbon dental implant with artificial periodontal ligament
US4007494A (en) * 1975-04-11 1977-02-15 Glasrock Products, Inc. Bone cap
US3971679A (en) * 1975-09-02 1976-07-27 Armco Steel Corporation Method of annealing oriented silicon steel
US4164794A (en) * 1977-04-14 1979-08-21 Union Carbide Corporation Prosthetic devices having coatings of selected porous bioengineering thermoplastics
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
US4195409A (en) * 1978-02-13 1980-04-01 Child Laboratories Inc. Dental implant
US4244689A (en) * 1978-06-27 1981-01-13 Arthur Ashman Endosseous plastic implant
US4252525A (en) * 1979-12-17 1981-02-24 Child Frank W Dental implant
US4321914A (en) * 1980-04-22 1982-03-30 W. L. Gore & Associates, Inc. Percutaneous conduit having PTFE skirt
US4400833A (en) * 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4492390A (en) * 1981-08-20 1985-01-08 The Wessel Company, Inc. Combined airline ticket holder and advertising booklet
US4535485A (en) * 1982-03-12 1985-08-20 Medical Biological Sciences, Inc. Polymeric acrylic prothesis
US4492577A (en) * 1982-10-25 1985-01-08 Farris Edward T Surgical implants with solid interiors and porous surfaces
US4531916A (en) * 1983-07-08 1985-07-30 W. L. Gore & Associates, Inc. Dental implant with expanded PTFE gingival interface
JPS61122855A (ja) * 1984-07-06 1986-06-10 ダブリユ.エル.ゴア アンド アソシエイツ,インコ−ポレイテイド 歯周症の治療用製品
SE450623B (sv) * 1984-11-07 1987-07-13 Dan Lundgren Element for kontrollerad vevnadsinvext i kirurgiskt intervenerade omraden
SE8804641D0 (sv) * 1988-12-23 1988-12-23 Procordia Oratech Ab Surgical barrier
US5171148A (en) * 1989-06-30 1992-12-15 Ethicon, Inc. Dental inserts for treatment of periodontal disease

Also Published As

Publication number Publication date
DE69018457T2 (de) 1995-12-07
JPH04506467A (ja) 1992-11-12
US5093179A (en) 1992-03-03
HK165695A (en) 1995-11-03
DE69018457D1 (de) 1995-05-11
JP2905592B2 (ja) 1999-06-14
WO1990011730A1 (en) 1990-10-18
EP0466820A1 (de) 1992-01-22

Similar Documents

Publication Publication Date Title
EP0466820B1 (de) Gegenstände zur behandlung von periodontitis und knochendefekten
US5032445A (en) Methods and articles for treating periodontal disease and bone defects
Scantlebury 1982‐1992: A decade of technology development for guided tissue regeneration
US5700479A (en) Surgical element and method for selective tissue regeneration
EP1069874B1 (de) Membran mit gewellter Oberfläche zur Führung des Gewebes
Jovanovic et al. Supracrestal bone formation around dental implants: an experimental dog study.
EP0560934B1 (de) Implantierbare bioresorbierbare artikel
CA1246905A (en) Dental implant with expanded ptfe gingival interface
US8556990B2 (en) Reinforced PTFE medical barriers
EP2959862B1 (de) Perforierte membran zur geführten knochen- und geweberegeneration
JPH03505684A (ja) 外科用バリア
FI78824B (fi) Foeremaol foer behandling av periodontal sjukdom.
US6019764A (en) Method of treating alveolar bone defects
Papacharalambous et al. Natural coral skeleton used as on lay graft for contour augmentation of the face. A preliminary report
El Deeb et al. Porous hydroxylapatite granules and blocks as alveolar ridge augmentation materials: a preliminary report
EP0773750A1 (de) Chirurgisches element sowie verfahren zur selektiven geweberegeneration
US5607689A (en) Latex element designed to achieve guided tissue regeneration in periodontal dental therapy
CA2217036A1 (en) Cover diaphragm
Kinoshita et al. Study on the efficacy of biodegradable polyf (l-lactide) mesh for supporting transplanted particulate cancellous bone and marrow: experiment involving subcutaneous implantation in dogs
Fontana et al. Freeze‐dried dura mater for guided tissue regeneration in post‐extraction dental implants: a clinical and histologic study
CN108283732B (zh) 一种用于牙槽骨骨增量的植骨复合材料
CN219022453U (zh) 一种口腔骨组织修复系统
Pi-Anfruns et al. Guided Bone Regeneration (GBR) for Implants in the Aesthetic Zone
JP2001511677A (ja) 骨移植組織
Rajpal et al. Membrane Guided Regeneration in Periodontal Tissues

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910822

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MOTSINGER, SUZANNE

Inventor name: DAVIDSON, DANIEL, F.

Inventor name: SCANTLEBURY, TODD, V.

Inventor name: AMBRUSTER, JEANNE, B.

Inventor name: HARDWICK, WILLIAM, ROSS

Inventor name: CAMPBELL, STEPHEN, E.

17Q First examination report despatched

Effective date: 19920527

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB SE

REF Corresponds to:

Ref document number: 69018457

Country of ref document: DE

Date of ref document: 19950511

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20090429

Year of fee payment: 20

Ref country code: FR

Payment date: 20090417

Year of fee payment: 20

Ref country code: DE

Payment date: 20090429

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20090429

Year of fee payment: 20

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20100403

EUG Se: european patent has lapsed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20100403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20100404